Viewing StudyNCT00365222



Ignite Creation Date: 2024-05-05 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00365222
Status: TERMINATED
Last Update Posted: 2009-01-22
First Post: 2006-08-15

Brief Title: Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: H Lee Moffitt Cancer Center and Research Institute

Organization Data

Organization: H Lee Moffitt Cancer Center and Research Institute
Class: OTHER
Study ID: MCC-14714
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Marc Chamberlain MD
Old Organization: H Lee Moffitt Cancer Center and Research Institute

Collaborators

Name Class
Schering-Plough INDUSTRY